Zafgen (ZFGN) News Today → Has Jeff Bezos Found the Next Nvidia? (From InvestorPlace) (Ad) Free ZFGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGlobal Weight Loss Therapeutics Professional Market 2023 (Exclusive Report) | Future Work Trend by 2030marketwatch.com - April 9 at 10:32 AMZafgen (ZFGN) Stock Skyrockets on Positive Obesity Drug Resultsthestreet.com - February 26 at 7:51 PMZafgen (ZFGN) Stock Surges on Positive Obesity Drug Trialthestreet.com - January 13 at 3:45 PMFood and drink in a castlebbc.co.uk - November 8 at 8:12 PMLRMR Larimar Therapeutics, Inc.seekingalpha.com - September 30 at 10:25 AMForm 424B5 Larimar Therapeutics, - StreetInsider.comstreetinsider.com - September 14 at 8:07 AMForm DEF 14A Larimar Therapeutics, For: May 10 - StreetInsider.comstreetinsider.com - April 12 at 7:07 PMLARIMAR THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.commarketscreener.com - March 25 at 3:29 PMLARIMAR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.commarketscreener.com - November 12 at 3:33 PMLarimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results - StreetInsider.comstreetinsider.com - November 12 at 3:33 PMLarimar Therapeutics Reports Third Quarter 2021 Operating - GlobeNewswireglobenewswire.com - November 12 at 8:50 AMAnti-Obesity Therapeutics Market Research Report by Mechanism of Action, by Drug Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo Financefinance.yahoo.com - October 22 at 9:06 AMAnti-Obesity Therapeutics Market Research Report by Mechanism of Action, by Drug Type, by Region - Global - Benzingabenzinga.com - October 20 at 9:39 AMFauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery - StreetInsider.comstreetinsider.com - September 21 at 3:15 PMFauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery - PRNewswireprnewswire.com - September 21 at 10:14 AMVividion Therapeutics Begins U.S. IPO Effort - Seeking Alphaseekingalpha.com - August 2 at 9:06 PM Get Zafgen News Delivered to You Automatically Sign up to receive the latest news and ratings for ZFGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Jeff Bezos Found the Next Nvidia? (Ad)If you’ve sat back and watched companies like Nvidia and AMD soar over 2,000% over the past several years… And wondered what was next… This is a fast-moving story, but if you want the chance to profit alongside Jeff Bezos in the next big tech trend, go ahead and… Click Here for Full Details ZFGN Media Mentions By Week ZFGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZFGN News Sentiment▼0.000.33▲Average Medical News Sentiment ZFGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZFGN Articles This Week▼00▲ZFGN Articles Average Week Get Zafgen News Delivered to You Automatically Sign up to receive the latest news and ratings for ZFGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ME News TSVT News VSTM News ACIU News PBYI News XBIT News ALDX News XERS News CDT News OVID News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZFGN) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zafgen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
